Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform has the potential to provide treatment to patients in several established neurostimulator markets including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other emerging neurostimulator markets. The company was founded by Mark C. Bates and Ralph L. Ballard, III in 2005 and is headquartered in Dallas, TX.
Company profile
Ticker
NXNN
Exchange
Website
CEO
William Michael Rosellini
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
NEXEON MEDSYSTEMS, INC, Paragon Intellectual Properties LLC
SEC CIK
Corporate docs
NXNN stock data
Latest filings (excl ownership)
8-K
Changes in Control of Registrant
9 Apr 21
15-12G
Securities registration termination
7 Apr 21
8-K
Changes in Control of Registrant
27 Nov 20
8-K
Departure of Directors or Certain Officers
1 Apr 19
NT 10-K
Notice of late annual filing
1 Apr 19
RW
Registration withdrawal request
8 Feb 19
S-1/A
IPO registration (amended)
17 Dec 18
S-1/A
IPO registration (amended)
13 Dec 18
8-K
Regulation FD Disclosure
11 Dec 18
S-1/A
IPO registration (amended)
7 Dec 18
Latest ownership filings
SC 13G
Nexeon Medsystems Inc
15 Jan 19
3
Family Irrv Tr 2 Rosellini
15 Jan 19
4
Family Irrevocable Trust UA Dated 09/24/2018 Rosellini
9 Jan 19
4
William Rosellini
9 Jan 19
SC 13G/A
Nexeon Medsystems Inc
9 Jan 19
SC 13D/A
Nexeon Medsystems Inc
9 Jan 19
SC 13G
Nexeon Medsystems Inc
24 Dec 18
3
Jamie Tunnell Harris
21 Dec 18
SC 13D
Nexeon Medsystems Inc
19 Nov 18
4
William Rosellini
16 Nov 18